# A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)

> **NCT02495519** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 21 (actual)

## Conditions studied

- Fibromatosis

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT02495519
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02495519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02495519, "A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02495519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*